Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Virus Challenge Trial of RG-A/Arkansas/08/2020 (pH1N1) in Healthy Adults
NCT07110532Phase 1Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in influenza (12 cohorts), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Number and percentage of participants reporting a related SAE at Day 57, Number and percentage of participants reporting any related AE at Day 29 and 1 more. Started Sep 2025; status: recruiting.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT07110532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07110532.